These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18190406)

  • 1. Assessment of substance abusers on the MCMI-III and the Rorschach.
    Vanem PC; Krog D; Hartmann E
    Scand J Psychol; 2008 Feb; 49(1):83-91. PubMed ID: 18190406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Contribution of dissociative symptoms to antisocial behavior in a sample of high-school students].
    Chabrol H; Saint-Martin C; Sejourné N; Moyano O
    Encephale; 2009 Feb; 35(1):52-6. PubMed ID: 19250994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The factor structure of the Millon Clinical Multiaxial Inventory (MCMI) for psychiatric inpatients.
    Piersma HL
    J Pers Assess; 1986; 50(4):578-84. PubMed ID: 3820051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Millon Clinical Multiaxial Inventory II: stability over time? A seven-year follow-up study of substance abusers in treatment.
    Ravndal E; Vaglum P
    Eur Addict Res; 2010; 16(3):146-51. PubMed ID: 20424459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MCMI-II diagnosis of schizophrenia: operating characteristics and profile analysis.
    del Rosario PM; McCann JT; Navarra JW
    J Pers Assess; 1994 Dec; 63(3):438-52. PubMed ID: 7844735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosing antisocial personality disorder among substance abusers: the scid versus the MCMI-II.
    Messina N; Wish E; Hoffman J; Nemes S
    Am J Drug Alcohol Abuse; 2001 Nov; 27(4):699-717. PubMed ID: 11727884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the diagnostic efficiency of the MMPI, MCMI-II, and Rorschach: a review.
    Ganellen RJ
    J Pers Assess; 1996 Oct; 67(2):219-43. PubMed ID: 8828186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV risk and history of STDs in MCMI-III psychopathology subgroups of comorbid substance abusers.
    McMahon RC; Malow RM; Devieux J; Rosenberg R; Jennings T
    Am J Drug Alcohol Abuse; 2008; 34(3):329-37. PubMed ID: 18428075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of defensive responding by substance-abusing patients on the Million Clinical Multiaxial Inventory.
    Fals-Stewart W
    J Pers Assess; 1995 Jun; 64(3):540-51. PubMed ID: 7760260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in axis I and axis II comorbidity in patients with borderline personality disorder.
    Tadić A; Wagner S; Hoch J; Başkaya O; von Cube R; Skaletz C; Lieb K; Dahmen N
    Psychopathology; 2009; 42(4):257-63. PubMed ID: 19521142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Convergent validity of MCMI-III clinical syndrome scales.
    Hesse M; Guldager S; Linneberg IH
    Br J Clin Psychol; 2012 Jun; 51(2):172-84. PubMed ID: 22574802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables.
    Pozzi G; Martinotti G; Reina D; Dario T; Frustaci A; Janiri L; Bria P
    Subst Use Misuse; 2008; 43(5):722-32. PubMed ID: 18393086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of MCMI subtle and obvious subscales to detect faking.
    Wierzbicki M
    J Clin Psychol; 1993 Nov; 49(6):809-14. PubMed ID: 8300869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exploration of the base rate scores of the Millon Clinical Multiaxial Inventory-III.
    Grove WM; Vrieze SI
    Psychol Assess; 2009 Mar; 21(1):57-67. PubMed ID: 19290766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Some Rorschach data of schizophrenics].
    Li QX
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Oct; 22(5):269-73, 317. PubMed ID: 2636095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The Rorschach test in the diagnosis of schizophrenia].
    Zaniecka M; Rybakowski J
    Psychiatr Pol; 1989; 23(4):300-6. PubMed ID: 2631129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evolution of treatment and consumption in persons with cocaine dependence, at 12-months, in respect of the associated psychopathology and daily functioning].
    López Durán A; Becoña Iglesias E; Lloves Moratinos M; Moneo Montes A; Vieitez Fernández I; Cancelo Martínez J; Estévez Vorkauf C; Sobradelo Lens J; García Janeiro JM; Senra Comesaña A; Fernandez Lorena C; Lage López MT; Díaz Castro E
    Adicciones; 2007; 19(3):251-65. PubMed ID: 17724927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of subtle and obvious scales to detect faking on the MCMI-II.
    Wierzbicki M
    J Clin Psychol; 1997 Aug; 53(5):421-6. PubMed ID: 9257219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linking personality disorders and clinical syndromes on the MCMI-III.
    Haddy C; Strack S; Choca JP
    J Pers Assess; 2005 Apr; 84(2):193-204. PubMed ID: 15799894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.